BioMarin Pharmaceutical Inc. (BMRN Quick QuoteBMRN - Free Report) was a big mover last session, as its shares rose almost 7% on the day. The upside was driven by positive interim results of an open-label Phase 1/2 study of BMN 270 – an investigational gene therapy treatment for severe hemophilia A. This also led to far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $77.80 to $93.76 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

BioMarin Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

BIOMARIN PHARMA Price

BIOMARIN PHARMA Price | BIOMARIN PHARMA Quote

A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. (ANIP Quick QuoteANIP - Free Report) with a Zacks Rank #1 (Strong Buy).

Is BMRN going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>